BUONTEMPO, FRANCESCA
BUONTEMPO, FRANCESCA
DIPARTIMENTO DI SCIENZE BIOMEDICHE E NEUROMOTORIE
Assegnisti
9-Hydroxystearic acid upregulates p21WAF1 in HT29 cancer cells.
2004 N. CALONGHI; C. CAPPADONE; E. PAGNOTTA; G. FARRUGGIA; F. BUONTEMPO; C. BOGA; G.L. BRUSA; M.A. SANTUCCI; MASOTTI L.
A COMBINATION OF BORTEZOMIB WITH CX-4945, A CASEIN KINASE 2 (CK2) INHIBITOR, HAS SYNERGISTIC CYTOTOXIC EFFECTS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CELL LINES
2014 Buontempo F; Orsini E; Cappellini A; Lonetti A; Evangelisti C; Chiarini F; Spartà AM; Bressanin D; Evangelisti C; Martelli AM
A COMBINATION OF BORTEZOMIB WITH CX-4945, A CASEIN KINASE 2 (CK2) INHIBITOR, HAS SYNERGISTIC CYTOTOXIC EFFECTS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CELL LINES
2014 Buontempo, Francesca; Orsini, E; Cappellini, Alessandra; Lonetti, Annalisa; Evangelisti, C; Chiarini, Francesca; Spartà, Am; Bressanin, D; Evangelisti, C; Martelli, Am
Activity of the pan-class I phosphoinositide 3-kinase inhibitor NVP-BKM120 in T-cell acute lymphoblastic leukemia
2014 A. Lonetti; I. Lopes Antunes; F. Chiarini; E. Orsini; F. Buontempo; F. Ricci; P.L. Tazzari; P. Pagliaro; F. Melchionda; A. Pession; A. Bertaina; F. Locatelli; J.A. McCubrey; J.T. Barata; A.M. Martelli.
Activity of the Selective IκB kinase Inhibitor BMS-345541 against T-Cell Acute Lymphoblastic Leukemia: involvement of FOXO3a
2012 F. Buontempo; F. Chiarini; D. Bressanin; G. Tabellini; F. Melchionda; A. Pession; M. Fini; L.M. Neri; J.A. McCubrey; A.M. Martelli
Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: from biology to therapeutic targeting.
2016 Chiarini, F; Lonetti, A; Evangelisti, C; Buontempo, F; Orsini, E; Evangelisti, C; Cappellini, A; Neri, LM; McCubrey, Ja; Martelli, AM.
Antioxidants in the prevention of UVB-induced keratynocyte apoptosis.
2014 S. Salucci; S. Burattini; D. Curzi; F. Buontempo; A.M. Martelli; G. Zappia; E. Falcieri; M. Battistelli.
ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS
2014 Evangelisti C; Evangelisti C; Teti G; Falconi M; Cappellini A; Chiarini F; Buontempo F; Bressanin D; Lonetti A; Spartà A; Bittman R; Pyne S; Pyne N; Martelli AM
ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS
2014 Evangelisti, C; Evangelisti, C; Teti, G; Falconi, M; Cappellini, A; Chiarini, F; Buontempo, F; Bressanin, D; Lonetti, A; Spartà, A; Bittman, R; Pyne, S; Pyne, N; Martelli, Am
Autophagy in acute leukemias: a double-edged sword with important therapeutic implications.
2015 Cecilia Evangelisti; Camilla Evangelisti; Francesca Chiarini; Annalisa Lonetti; Francesca Buontempo; Luca Maria Neri; James A. McCubrey; Alberto Maria Martelli.
Characterization of biological effects in radiotherapy applications of ultra-high dose rate pulses from a plasma focus device
2016 Buontempo, F.; Isolan, L.; Zironi, I.; Castellani, G.; Nano, R.; Pasi, F.; Tartari, A.; Mostacci, D.; Sumini, M.; Martelli, A.M.
Compact and very high dose-rate plasma focus radiation sources for medical applications
2022 Lorenzo Isolan, Davide Laghi, Isabella Zironi, Marta Cremonesi, Cristina Garibaldi, Francesca Buontempo, Marco Sumini
Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling
2014 F. Buontempo; E. Orsini; L.R. Martins; I. Antunes; A. Lonetti; F. Chiarini; G. Tabellini; C. Evangelisti; C. Evangelisti; F. Melchionda; A. Pession; A. Bertaina; F. Locatelli; J.A. McCubrey; A. Cappellini; J.T. Barata; A.M. Martelli.
Diet modulation restores autophagic flux in damaged skeletal muscle cells.
2019 F.M. Giordano, S. Burattini, F. Buontempo, B. Canonico, A.M. Martelli, S. Papa, M. Sampaolesi, E. Falcieri, S. Salucci.
Dose-current discharge correlation analysis in a Mather type Plasma Focus device for medical applications
2017 Sumini, M.; Mostacci, D.; Tartari, A.; Mazza, A.; Cucchi, G.; Isolan, L.; Buontempo, F.; Zironi, I.; Castellani, G.
Dosimetric analysis and experimental setup design for in-vivo irradiation with a Plasma Focus device
2019 Isolan, L.; Sumini, M.*; Teodori, F.; Bradley, D.; Jafari, S.; Mariotti, F.; Buontempo, F.
Drug discovery targeting the mTOR pathway
2018 A.M. Martelli, F. Buontempo, J.A. McCubrey
Early biological effects of ultra-high compare to standard dose rate of X-rays on a radioresistant cell line
2016 Zironi, I.; Buontempo, F.; Petrigliano, S.; Salvatore, D.; Rapino, S.; Isolan, L.; Zanella, S.; Orsini, E.; Martelli, A.M.; Castellani, G.; Sumini, M
Enhancing radiosensitivity of melanoma cells through very high dose rate pulses released by a plasma focus device
2018 Buontempo, Francesca*; Orsini, Ester; Zironi, Isabella; Isolan, Lorenzo; Cappellini, Alessandra; Rapino, Stefania; Tartari, Agostino; Mostacci, Domiziano; Cucchi, Giorgio; Martelli, Alberto Maria; Sumini, Marco; Castellani, Gastone
Estrogen-deficient osteoporosis enhances the recruitment and activity of osteoclasts by breast cancer cells
2016 Salamanna, Francesca; Pagani, Stefania; Maglio, Melania; Borsari, Veronica; Giavaresi, Gianluca; Alberto M. Martelli, ; Buontempo, Francesca; Fini, Milena
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| 9-Hydroxystearic acid upregulates p21WAF1 in HT29 cancer cells. | N. CALONGHI; C. CAPPADONE; E. PAGNOTTA; G. FARRUGGIA; F. BUONTEMPO; C. BOGA; G.L. BRUSA; M.A. SAN...TUCCI; MASOTTI L. | 2004-01-01 | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | - | 1.01 Articolo in rivista | - |
| A COMBINATION OF BORTEZOMIB WITH CX-4945, A CASEIN KINASE 2 (CK2) INHIBITOR, HAS SYNERGISTIC CYTOTOXIC EFFECTS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CELL LINES |
Buontempo F; Orsini E; Cappellini A; Lonetti A; Evangelisti C; Chiarini F; Spartà AM; Bressanin D...; Evangelisti C; Martelli AM |
2014-01-01 | HAEMATOLOGICA | - | 4.03 Poster | - |
| A COMBINATION OF BORTEZOMIB WITH CX-4945, A CASEIN KINASE 2 (CK2) INHIBITOR, HAS SYNERGISTIC CYTOTOXIC EFFECTS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CELL LINES | Buontempo, Francesca; Orsini, E; Cappellini, Alessandra; Lonetti, Annalisa; Evangelisti, C; Chiar...ini, Francesca; Spartà, Am; Bressanin, D; Evangelisti, C; Martelli, Am | 2014-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| Activity of the pan-class I phosphoinositide 3-kinase inhibitor NVP-BKM120 in T-cell acute lymphoblastic leukemia | A. Lonetti; I. Lopes Antunes; F. Chiarini; E. Orsini; F. Buontempo; F. Ricci; P.L. Tazzari; P. Pa...gliaro; F. Melchionda; A. Pession; A. Bertaina; F. Locatelli; J.A. McCubrey; J.T. Barata; A.M. Martelli. | 2014-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | - |
| Activity of the Selective IκB kinase Inhibitor BMS-345541 against T-Cell Acute Lymphoblastic Leukemia: involvement of FOXO3a | F. Buontempo; F. Chiarini; D. Bressanin; G. Tabellini; F. Melchionda; A. Pession; M. Fini; L.M. N...eri; J.A. McCubrey; A.M. Martelli | 2012-01-01 | CELL CYCLE | - | 1.01 Articolo in rivista | - |
| Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: from biology to therapeutic targeting. | Chiarini, F; Lonetti, A; Evangelisti, C; Buontempo, F; Orsini, E; Evangelisti, C; Cappellini, A; ...Neri, LM; McCubrey, Ja; Martelli, AM. | 2016-01-01 | BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | - | 1.01 Articolo in rivista | - |
| Antioxidants in the prevention of UVB-induced keratynocyte apoptosis. | S. Salucci; S. Burattini; D. Curzi; F. Buontempo; A.M. Martelli; G. Zappia; E. Falcieri; M. Batti...stelli. | 2014-01-01 | JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY | - | 1.01 Articolo in rivista | - |
| ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS |
Evangelisti C; Evangelisti C; Teti G; Falconi M; Cappellini A; Chiarini F; Buontempo F; Bressanin... D; Lonetti A; Spartà A; Bittman R; Pyne S; Pyne N; Martelli AM |
2014-01-01 | HAEMATOLOGICA | - | 4.03 Poster | - |
| ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS | Evangelisti, C; Evangelisti, C; Teti, G; Falconi, M; Cappellini, A; Chiarini, F; Buontempo, F; Br...essanin, D; Lonetti, A; Spartà, A; Bittman, R; Pyne, S; Pyne, N; Martelli, Am | 2014-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| Autophagy in acute leukemias: a double-edged sword with important therapeutic implications. | Cecilia Evangelisti; Camilla Evangelisti; Francesca Chiarini; Annalisa Lonetti; Francesca Buontem...po; Luca Maria Neri; James A. McCubrey; Alberto Maria Martelli. | 2015-01-01 | BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | - | 1.01 Articolo in rivista | - |
| Characterization of biological effects in radiotherapy applications of ultra-high dose rate pulses from a plasma focus device | Buontempo, F.; Isolan, L.; Zironi, I.; Castellani, G.; Nano, R.; Pasi, F.; Tartari, A.; Mostacci,... D.; Sumini, M.; Martelli, A.M. | 2016-01-01 | - | Elsevier | 4.02 Riassunto (Abstract) | - |
| Compact and very high dose-rate plasma focus radiation sources for medical applications | Lorenzo Isolan, Davide Laghi, Isabella Zironi, Marta Cremonesi, Cristina Garibaldi, Francesca Buo...ntempo, Marco Sumini | 2022-01-01 | RADIATION PHYSICS AND CHEMISTRY | - | 1.01 Articolo in rivista | - |
| Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling | F. Buontempo; E. Orsini; L.R. Martins; I. Antunes; A. Lonetti; F. Chiarini; G. Tabellini; C. Evan...gelisti; C. Evangelisti; F. Melchionda; A. Pession; A. Bertaina; F. Locatelli; J.A. McCubrey; A. Cappellini; J.T. Barata; A.M. Martelli. | 2014-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | - |
| Diet modulation restores autophagic flux in damaged skeletal muscle cells. | F.M. Giordano, S. Burattini, F. Buontempo, B. Canonico, A.M. Martelli, S. Papa, M. Sampaolesi, E.... Falcieri, S. Salucci. | 2019-01-01 | THE JOURNAL OF NUTRITION, HEALTH & AGING | - | 1.01 Articolo in rivista | - |
| Dose-current discharge correlation analysis in a Mather type Plasma Focus device for medical applications | Sumini, M.; Mostacci, D.; Tartari, A.; Mazza, A.; Cucchi, G.; Isolan, L.; Buontempo, F.; Zironi, ...I.; Castellani, G. | 2017-01-01 | RADIATION PHYSICS AND CHEMISTRY | - | 1.01 Articolo in rivista | - |
| Dosimetric analysis and experimental setup design for in-vivo irradiation with a Plasma Focus device | Isolan, L.; Sumini, M.*; Teodori, F.; Bradley, D.; Jafari, S.; Mariotti, F.; Buontempo, F. | 2019-01-01 | RADIATION PHYSICS AND CHEMISTRY | - | 1.01 Articolo in rivista | - |
| Drug discovery targeting the mTOR pathway | A.M. Martelli, F. Buontempo, J.A. McCubrey | 2018-01-01 | CLINICAL SCIENCE | - | 1.01 Articolo in rivista | - |
| Early biological effects of ultra-high compare to standard dose rate of X-rays on a radioresistant cell line | Zironi, I.; Buontempo, F.; Petrigliano, S.; Salvatore, D.; Rapino, S.; Isolan, L.; Zanella, S.; O...rsini, E.; Martelli, A.M.; Castellani, G.; Sumini, M | 2016-01-01 | - | - | 4.03 Poster | - |
| Enhancing radiosensitivity of melanoma cells through very high dose rate pulses released by a plasma focus device | Buontempo, Francesca*; Orsini, Ester; Zironi, Isabella; Isolan, Lorenzo; Cappellini, Alessandra; ...Rapino, Stefania; Tartari, Agostino; Mostacci, Domiziano; Cucchi, Giorgio; Martelli, Alberto Maria; Sumini, Marco; Castellani, Gastone | 2018-01-01 | PLOS ONE | - | 1.01 Articolo in rivista | pone.0199312.pdf |
| Estrogen-deficient osteoporosis enhances the recruitment and activity of osteoclasts by breast cancer cells | Salamanna, Francesca; Pagani, Stefania; Maglio, Melania; Borsari, Veronica; Giavaresi, Gianluca; ...Alberto M. Martelli, ; Buontempo, Francesca; Fini, Milena | 2016-01-01 | HISTOLOGY AND HISTOPATHOLOGY | - | 1.01 Articolo in rivista | - |